Get the latest industry news first when you subscribe to our daily newsletter.

Sponsored Post
By Medtronic and MedCity News
Photo: ismagilov, Getty Images
Medtronic developed a way to reduce false alerts through its AccuRhythm™ AI algorithms. The algorithm is applied through cloud-based updates to all LINQ II™ Insertable Cardiac Monitors (ICMs) and helps improve the accuracy of information physicians receive so they can better diagnose and treat abnormal heart rhythms. 
The AccuRhythm AI algorithms are specific to the most common ICM false alerts, atrial fibrillation (AF) and pause (asystole) and are applied to the devices automatically with no action required from current LINQ II™ ICM patients. 
The AI technology analyzes features, patterns, and trends within the labeled ECGs to learn and distinguish true cardiac events from false positives.  False positives are suppressed while true positives are preserved to ensure clinicians are spending their time reviewing only the episodes that are clinically relevant.
To learn more about AccuRhythm AI Platform please fill out the form below to download an infographic explaining how it works.
Indications, Safety, and Warnings:
Afib, AI, atrial fibrillation, cardiac rhythms, cardiology, LINQ II, medical devices, Medtronic, remote patient monitoring, Sponsored Content, Sponsored Post
INVEST PharmaTech 2022
MedCity INVEST PharmaTech, a virtual event to be held July 26, 2022 is a virtual executive summit where established biopharma companies gather with health tech and digital health innovators to transform the industry. Reserve your spot now.>>
Get the latest industry news first when you subscribe to our newsletter.
Our Sites
© 2022 Breaking Media, Inc. All rights reserved. Registration or use of this site constitutes acceptance of our Terms of Service and Privacy Policy.
Privacy Center | Do not sell my information